<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bacitracin (ophthalmic): Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bacitracin (ophthalmic): Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Bacitracin (ophthalmic): Pediatric drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_general" data-topicid="97028" href="/d/html/97028.html" rel="external">see "Bacitracin (ophthalmic): Drug information"</a> and <a class="drug drug_patient" data-topicid="97031" href="/d/html/97031.html" rel="external">see "Bacitracin (ophthalmic): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="list_set htclist drugH1Div drugBrandNames" id="F25576588"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antibiotic, Ophthalmic</span></li></ul></div>
<div class="block dop drugH1Div" id="F24147715"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="aab655e5-c5a2-4da1-8280-0c510c5da54c">Ophthalmic infections</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Ophthalmic infections:</b> Infants, Children, and Adolescents: Ophthalmic: Apply ribbon 1 to 3 times daily.</p></div>
</div>
</div>
<div class="block doa drugH1Div" id="F24147716"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="97028" href="/d/html/97028.html" rel="external">see "Bacitracin (ophthalmic): Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ea26c018-86d5-475b-b931-e8bd7f5f72b5">Ocular infections</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:0em;display:inline">
<b>Ocular infections:</b> Ophthalmic:</p>
<p style="text-indent:-2em;margin-left:2em;">Blepharitis: Apply twice daily and at bedtime.</p>
<p style="text-indent:-2em;margin-left:2em;">Superficial infections of the conjunctiva and/or cornea: Apply up to every 3 to 4 hours for 10 days as determined by severity of infection.</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F24147701"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%: Hypersensitivity: Hypersensitivity reaction (7% [Hätinen 1985])</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%, postmarketing, and/or case reports: Contact dermatitis (Pichichero 2011)</p></div>
<div class="block coi drugH1Div" id="F24147698"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Hypersensitivity to bacitracin or any component of the formulation</p></div>
<div class="block war drugH1Div" id="F24147699"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Bacterial overgrowth: Prolonged use or use in absence of infectious presence may result in overgrowth of nonsusceptible organisms, particularly fungi; if new infection develops, initiate appropriate therapy.</p>
<p style="text-indent:-2em;margin-left:4em;">• Blurred vision: May cause blurred vision, which may impair physical or mental abilities; patients must be cautioned about performing tasks that require clear vision (eg, operating machinery or driving).</p>
<p style="text-indent:-2em;margin-left:4em;">• Hypersensitivity/anaphylaxis: Use with caution in patients who have been previously exposed to bacitracin; contact dermatitis (Pichichero 2011) has been reported and may take several days of use to develop. Discontinue use if signs of an allergic sensitization reaction are noted, including itching, swelling, and conjunctival erythema.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Contact lens wearers: Contact lenses should not be worn during treatment.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Should not be used in deep seated ocular infections or if infection is likely to become systemic. Patients who do not respond to topical ophthalmic bacitracin treatment following 10 days of use should be reevaluated to ascertain appropriateness of continued antibiotic use.</p></div>
<div class="block dosfc drugH1Div" id="F53079538"><span class="drugH1">Dosage Forms Considerations</span>
<p style="text-indent:0em;display:inline">Bacitracin may also be compounded extemporaneously for subconjunctival injection and topical application to the eye in strengths of between 5,000 to 10,000 units/mL (Allen 2010).</p></div>
<div class="block foc drugH1Div" id="F24147731"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Ointment, Ophthalmic [preservative free]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 500 units/g (3.5 g)</p></div>
<div class="block geq drugH1Div" id="F24147688"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F24147733"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Ointment</b> (Bacitracin Ophthalmic)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">500 units/g (per gram): $37.05</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block admp drugH1Div" id="F52614166"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Ophthalmic: For topical ophthalmic use only; apply directly to conjunctival sac; avoid gross contamination of ointment during application. For blepharitis: After carefully removing all scales and crusts, apply uniformly over lid margins.</p></div>
<div class="block adm drugH1Div" id="F24147718"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">Ophthalmic: For topical ophthalmic use only; do not inject into the eye. Avoid contamination of ointment during application. Avoid excess ointment application. Patients should be instructed on proper administration of eye ointments. Do not touch the tip of the applicator to any part of the eye or surrounding adjacent areas.</p>
<p style="text-indent:-2em;margin-left:2em;">Blepharitis: After carefully removing all scales and crusts, apply thin film uniformly over lid margins.</p>
<p style="text-indent:-2em;margin-left:2em;">Superficial infections of the conjunctiva and/or cornea: Apply thin ¼ inch strip directly into conjunctival sac.</p></div>
<div class="block sts drugH1Div" id="F24147702"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;margin-left:0em;display:inline">Store at 20°C to 25°C (68°F to 77°F).</p></div>
<div class="block usep drugH1Div" id="F53569951"><span class="drugH1">Use</span>
<p style="text-indent:0em;display:inline">Treatment of superficial ocular infections involving the conjunctiva or cornea due to bacterial infections (has activity against gram-positive bacilli) (FDA approved in pediatric patients [age not specified] and adults).</p></div>
<div class="block mst drugH1Div" id="F24147682"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Bacitracin may be confused with Bactrim, Bactroban</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F24574201"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F24574198"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pri drugH1Div" id="F24147695"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Bacitracin is not absorbed systemically following ophthalmic administration (Robert 2001). If ophthalmic agents are needed during pregnancy, the minimum effective dose should be used in combination with punctal occlusion to decrease potential exposure to the fetus (Samples 1988).</p></div>
<div class="block pha drugH1Div" id="F24147704"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">A cyclic peptide antibiotic that inhibits bacterial cell wall synthesis by preventing transfer of mucopeptides into the growing cell wall. Bacitracin is bacteriostatic in nature, but may be bactericidal depending on the antibiotic concentration and the susceptibility of the organism. The antibacterial spectrum is primarily gram positive with activity against staphylococci (including some penicillin G resistant strains), streptococci, anaerobic cocci, Clostridia, Corynebacterium, gonococci, meningococci, and fusobacteria. Other susceptible organisms include <i>Treponema pallidum</i>, <i>Treponema</i>
<i> vincentii</i>, and <i>Actinomyces israelii</i>. Development of bacitracin resistance is rare; however, resistance to <i>Staphylococcus aureus</i> has been reported (Suzuki 2011).</p></div>
<div class="block phk drugH1Div" id="F53079536"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Topical: Negligible</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Allen, Loyld V. Formulations. Bacitracin 10,000 units/mL ophthalmic solution. <i>International Journal of Pharmaceutical Compounding</i>. 2010;14(3):240.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bacitracin.1">
<a name="Bacitracin.1"></a>Bacitracin ophthalmic [prescribing information]. Allegan, MI: Perrigo; August 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-92811">
<a name="92811"></a>Baum JL. Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms. <i>Surv Ophthalmol</i>. 1979;24(2):97-105.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/bacitracin-ophthalmic-pediatric-drug-information/abstract-text/92811/pubmed" id="92811" target="_blank">92811</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Bennett JE, Dolin R, Blaser MJ, eds. <i>Mandell, Douglas, and Bennett's Principles and Practice of Infectious Disease.</i> 8th ed. Philadelphia, PA: Elsevier Saunders; 2015.</div>
</li>
<li>
<div class="reference">
                  Elsner P, Pevny I, Burg G. Anaphylaxis induced by topically applied bacitracin. <i>Am J Contact Dermat</i>. 1990;1:162-164.</div>
</li>
<li>
<div class="reference">
                  Farley M, Pak H, Carregal V, Engler R, James W. Anaphylaxis to topically applied bacitracin. <i>Am J Contact Dermat</i>. 1995:6:28-31.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-4050363">
<a name="4050363"></a>Hätinen A, Teräsvirta M, Fräki JE. Contact allergy to components in topical ophthalmologic preparations. <i>Acta Ophthalmol (Copenh)</i>. 1985;63(4):424-426.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/bacitracin-ophthalmic-pediatric-drug-information/abstract-text/4050363/pubmed" id="4050363" target="_blank">4050363</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20724317">
<a name="20724317"></a>Pichichero ME. Bacterial conjunctivitis in children: antibacterial treatment options in an era of increasing drug resistance. <i>Clin Pediatr (Phila)</i>. 2011;50(1):7-13. doi: 10.1177/0009922810379045.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/bacitracin-ophthalmic-pediatric-drug-information/abstract-text/20724317/pubmed" id="20724317" target="_blank">20724317</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11270936">
<a name="11270936"></a>Robert PY, Adenis JP. Comparative review of topical ophthalmic antibacterial preparations. <i>Drugs</i>. 2001;61(2):175-185. doi: 10.2165/00003495-200161020-00003.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/bacitracin-ophthalmic-pediatric-drug-information/abstract-text/11270936/pubmed" id="11270936" target="_blank">11270936</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2903673">
<a name="2903673"></a>Samples JR, Meyer SM. Use of ophthalmic medications in pregnant and nursing women. <i>Am J Ophthalmol</i>. 1988;106(5):616-623.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/bacitracin-ophthalmic-pediatric-drug-information/abstract-text/2903673/pubmed" id="2903673" target="_blank">2903673</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16378567">
<a name="16378567"></a>Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update. <i>Br J Gen Pract</i>. 2005;55(521):962-964.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/bacitracin-ophthalmic-pediatric-drug-information/abstract-text/16378567/pubmed" id="16378567" target="_blank">16378567</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22000371">
<a name="22000371"></a>Suzuki M, Yamada K, Nagao M, et al. Antimicrobial ointments and methicillin-resistant Staphylococcus aureus USA300. <i>Emerg Infect Dis</i>. 2011;17(10):1917-1920. doi: 10.3201/eid1710.101365.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/bacitracin-ophthalmic-pediatric-drug-information/abstract-text/22000371/pubmed" id="22000371" target="_blank">22000371</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 97145 Version 70.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
